Notes
2005 US dollars
Reference
Versteegh M. Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis. PharmacoEconomics : 9 Jun 2016. Available from: URL: http://doi.org/10.1007/s40273-016-0421-0
Rights and permissions
About this article
Cite this article
ICERs higher in Markov model for MS using alternatives to EQ-5D. PharmacoEcon Outcomes News 756, 24 (2016). https://doi.org/10.1007/s40274-016-3173-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3173-3